Variant report
Variant | esv3339148 |
---|---|
Chromosome Location | chr8:87004236-87005384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1021171 | chr8:87004250-87004251 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74606872 | chr8:87004280-87004281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552654260 | chr8:87004292-87004293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192558654 | chr8:87004317-87004318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572502934 | chr8:87004318-87004319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570965280 | chr8:87004338-87004339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564609070 | chr8:87004357-87004358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533708407 | chr8:87004384-87004385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543774136 | chr8:87004413-87004414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28567526 | chr8:87004468-87004469 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs529466340 | chr8:87004514-87004515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549494630 | chr8:87004521-87004522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149389121 | chr8:87004546-87004547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558124705 | chr8:87004654-87004655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs60868824 | chr8:87004661-87004662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61565749 | chr8:87004677-87004678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs58821102 | chr8:87004688-87004689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs58966749 | chr8:87004689-87004690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528476940 | chr8:87004696-87004697 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs28566170 | chr8:87004708-87004709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183136794 | chr8:87004715-87004716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571571408 | chr8:87004728-87004729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537320433 | chr8:87004730-87004731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556986376 | chr8:87004781-87004782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78002849 | chr8:87004868-87004869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536091602 | chr8:87004926-87004927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552641027 | chr8:87004962-87004963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548319389 | chr8:87004980-87004981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572636791 | chr8:87004998-87004999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544583961 | chr8:87005008-87005009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558498897 | chr8:87005081-87005082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575140079 | chr8:87005087-87005088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544045860 | chr8:87005116-87005117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113109814 | chr8:87005160-87005161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563873116 | chr8:87005175-87005176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529499902 | chr8:87005191-87005192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376933 | chr8:87005194-87005195 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs559860308 | chr8:87005197-87005198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192227890 | chr8:87005208-87005209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551597820 | chr8:87005216-87005217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144672950 | chr8:87005256-87005257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373894832 | chr8:87005260-87005261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530815973 | chr8:87005268-87005269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185235410 | chr8:87005322-87005323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567492153 | chr8:87005377-87005378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Autism | 20841430 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Chordoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:86999600-87005200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr8:86999600-87005400 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
3 | chr8:87000000-87004400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:87002800-87007400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr8:87003200-87005800 | Enhancers | Brain Anterior Caudate | brain |
6 | chr8:87003200-87005800 | Enhancers | Brain Hippocampus Middle | brain |
7 | chr8:87003200-87008000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr8:87003400-87004600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr8:87003400-87004600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr8:87003400-87006000 | Enhancers | Brain Cingulate Gyrus | brain |
11 | chr8:87003400-87006400 | Enhancers | Brain Substantia Nigra | brain |
12 | chr8:87003600-87007800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr8:87003800-87006000 | Enhancers | Brain Inferior Temporal Lobe | brain |
14 | chr8:87004000-87005000 | Weak transcription | Brain Angular Gyrus | brain |
15 | chr8:87004200-87005200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr8:87004400-87016600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr8:87004600-87005000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr8:87004600-87005000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
19 | chr8:87005000-87005800 | Enhancers | Brain Angular Gyrus | brain |
20 | chr8:87005000-87006400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
21 | chr8:87005000-87007800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr8:87005200-87005400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
23 | chr8:87005200-87005800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr8:87005200-87006800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |